A glükagonszerű peptid-1 (GLP1) és a gyomor-bél rendszer. GLP1-receptor-agonisták – túlértékelt gyomor-, elfelejtődött bél- („ileal brake”) hatás?

Glucagon-like peptide-1 (GLP1) and their receptor agonists - beside their blood glucose lowering and central effects- affect also the gastrointestinal function in many respects. They slow down the stomach emptying, the motility of the small bowel and colon - this is the explanation for the "ileal brake" terminology -, stimulate the function of exocrine pancreatic acinar cells and increase amylase production. GLP1 receptor agonists belong to the...